George F. Njoroge

发表

Tricyclic Farnesyl Protein Transferase Inhibitors: Antitumor Activity and Effects on Protein Prenylation

W. R. Bishop, P. Kirschmeier, L. Armstrong, 2000 .

Novel Tricyclic Inhibitors of Farnesyl Protein Transferase

W. R. Bishop, P. Kirschmeier, J. Schwartz, 1995, The Journal of Biological Chemistry.

I. Novel HCV NS5B polymerase inhibitors: discovery of indole 2-carboxylic acids with C3-heterocycles.

B. Feld, R. Palermo, J. Duca, 2011, Bioorganic & medicinal chemistry letters.

Discovery of Boceprevir and Narlaprevir: A Case Study for Role of Structure‐Based Drug Design

A. Prongay, George F. Njoroge, S. Venkatraman, 2012 .

Discovery of C-imidazole azaheptapyridine FPT inhibitors.

W. R. Bishop, P. Kirschmeier, R. Doll, 2010, Bioorganic & medicinal chemistry letters.

Current drug discovery strategies for treatment of hepatitis C virus infection

Samir K. Gupta, E. Hughes, A. Uss, 2011, The Journal of pharmacy and pharmacology.

Discovery of fused tricyclic core containing HCV NS5A inhibitors with pan-genotype activity.

James I. Fells, E. Asante-Appiah, C. Coburn, 2016, Bioorganic & medicinal chemistry letters.

Screening and rank ordering of reversible mechanism-based inhibitors of hepatitis C virus NS3 protease using electrospray ionization mass spectrometry.

B. Malcolm, Yan-Hui Liu, B. Pramanik, 2011, Journal of mass spectrometry : JMS.

Current drug discovery strategies for treatment of hepatitis C virus infection

Samir K. Gupta, E. Hughes, A. Uss, 2011, The Journal of pharmacy and pharmacology.

Novel Tricyclic Inhibitors of Farnesyl Protein Transferase BIOCHEMICAL CHARACTERIZATION AND INHIBITION OF Ras MODIFICATION IN TRANSFECTED Cos CELLS*

P. Kirschmeier, J. Catino, R. Doll, 1995 .